Baldwin Wealth Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-771
Closed -$77K 572
2019
Q3
$77K Hold
771
0.01% 260
2019
Q2
$71K Sell
771
-5
-0.6% -$475 0.01% 278
2019
Q1
$73K Hold
776
0.01% 267
2018
Q4
$50K Hold
776
0.01% 292
2018
Q3
$69K Sell
776
-20
-3% -$1.77K 0.01% 280
2018
Q2
$63K Sell
796
-3,433
-81% -$285K 0.01% 289
2018
Q1
$377K Buy
4,229
+1,900
+82% +$182K 0.06% 143
2017
Q4
$243K Sell
2,329
-4,320
-65% -$487K 0.04% 184
2017
Q3
$970K Sell
6,649
-21
-0.3% -$2.86K 0.16% 91
2017
Q2
$866K Sell
6,670
-1,000
-13% -$123K 0.14% 97
2017
Q1
$954K Buy
7,670
+3,894
+103% +$466K 0.16% 92
2016
Q4
$437K Buy
3,776
+246
+7% +$27.4K 0.08% 128
2016
Q3
$369K Sell
3,530
-2,499
-41% -$270K 0.07% 139
2016
Q2
$594K Hold
6,029
0.12% 103
2016
Q1
$603K Sell
6,029
-1,564
-21% -$161K 0.11% 131
2015
Q4
$909K Buy
7,593
+390
+5% +$45.1K 0.15% 126
2015
Q3
$779K Sell
7,203
-417
-5% -$51.7K 0.13% 136
2015
Q2
$882K Buy
7,620
+1,200
+19% +$137K 0.13% 137
2015
Q1
$740K Buy
6,420
+160
+3% +$19.1K 0.11% 145
2014
Q4
$700K Hold
6,260
0.1% 153
2014
Q3
$593K Hold
6,260
0.08% 171
2014
Q2
$538K Buy
6,260
+360
+6% +$27.4K 0.08% 168
2014
Q1
$412K Hold
5,900
0.07% 175
2013
Q4
$498K Buy
5,900
+1,200
+26% +$95K 0.08% 167
2013
Q3
$362K Buy
+4,700
New +$329K 0.07% 174

Other funds holding CELG

Baldwin Wealth Partners's CELG Position: Q4 2019 in Review

Baldwin Wealth Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 771 shares — an estimated $77K sold.

Baldwin Wealth Partners first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $970K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Baldwin Wealth Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Baldwin Wealth Partners sold 771 Celgene Corp shares in Q4 2019, an estimated $77K.
  • Baldwin Wealth Partners first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • Baldwin Wealth Partners's Celgene Corp position peaked at $970K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Baldwin Wealth Partners's 13F filing for Q4 2019, filed 29 Jan 2020.